Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 231.0
(0.87%)
JPY 231.0
(0.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2 Billion JPY | 2.72% |
| 2022 | 1.95 Billion JPY | -13.24% |
| 2021 | 2.25 Billion JPY | 14.91% |
| 2020 | 1.95 Billion JPY | -20.5% |
| 2019 | 2.46 Billion JPY | -0.41% |
| 2018 | 2.47 Billion JPY | 17.03% |
| 2017 | 2.11 Billion JPY | -14.14% |
| 2016 | 2.46 Billion JPY | -7.02% |
| 2015 | 2.64 Billion JPY | 10.94% |
| 2014 | 2.38 Billion JPY | 14.07% |
| 2013 | 2.09 Billion JPY | -8.28% |
| 2012 | 2.28 Billion JPY | -1.44% |
| 2011 | 2.31 Billion JPY | 4.79% |
| 2010 | 2.2 Billion JPY | 31.83% |
| 2009 | 1.67 Billion JPY | -6.21% |
| 2008 | 1.78 Billion JPY | 15.34% |
| 2007 | 1.54 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.09 Billion JPY | 4.33% |
| 2023 Q3 | 2.04 Billion JPY | 2.63% |
| 2023 Q4 | 2 Billion JPY | -2.13% |
| 2023 Q1 | 1.88 Billion JPY | -3.59% |
| 2023 FY | 2 Billion JPY | 2.72% |
| 2023 Q2 | 1.99 Billion JPY | 6.09% |
| 2022 Q1 | 2.18 Billion JPY | -3.08% |
| 2022 FY | 1.95 Billion JPY | -13.24% |
| 2022 Q4 | 1.95 Billion JPY | -3.56% |
| 2022 Q3 | 2.02 Billion JPY | -5.41% |
| 2022 Q2 | 2.14 Billion JPY | -1.87% |
| 2021 Q2 | 2.11 Billion JPY | 5.57% |
| 2021 Q4 | 2.25 Billion JPY | 5.83% |
| 2021 Q3 | 2.12 Billion JPY | 0.74% |
| 2021 FY | 2.25 Billion JPY | 14.91% |
| 2021 Q1 | 2 Billion JPY | 2.11% |
| 2020 Q4 | 1.95 Billion JPY | -5.57% |
| 2020 Q1 | 2.5 Billion JPY | 1.86% |
| 2020 Q2 | 2.38 Billion JPY | -5.02% |
| 2020 Q3 | 2.07 Billion JPY | -12.98% |
| 2020 FY | 1.95 Billion JPY | -20.5% |
| 2019 Q4 | 2.46 Billion JPY | 2.61% |
| 2019 FY | 2.46 Billion JPY | -0.41% |
| 2019 Q3 | 2.4 Billion JPY | -5.77% |
| 2019 Q2 | 2.54 Billion JPY | -0.06% |
| 2019 Q1 | 2.54 Billion JPY | 3.06% |
| 2018 Q3 | 2.34 Billion JPY | 4.05% |
| 2018 FY | 2.47 Billion JPY | 17.03% |
| 2018 Q4 | 2.47 Billion JPY | 5.65% |
| 2018 Q2 | 2.25 Billion JPY | 4.19% |
| 2018 Q1 | 2.16 Billion JPY | 2.18% |
| 2017 Q4 | 2.11 Billion JPY | -3.63% |
| 2017 FY | 2.11 Billion JPY | -14.14% |
| 2017 Q3 | 2.19 Billion JPY | -2.28% |
| 2017 Q2 | 2.24 Billion JPY | -4.15% |
| 2017 Q1 | 2.34 Billion JPY | -4.88% |
| 2016 Q1 | 2.5 Billion JPY | -5.54% |
| 2016 FY | 2.46 Billion JPY | -7.02% |
| 2016 Q4 | 2.46 Billion JPY | 9.04% |
| 2016 Q3 | 2.25 Billion JPY | -3.91% |
| 2016 Q2 | 2.35 Billion JPY | -6.05% |
| 2015 Q2 | 2.72 Billion JPY | 10.59% |
| 2015 FY | 2.64 Billion JPY | 10.94% |
| 2015 Q4 | 2.64 Billion JPY | -0.79% |
| 2015 Q1 | 2.46 Billion JPY | 3.27% |
| 2015 Q3 | 2.66 Billion JPY | -2.09% |
| 2014 FY | 2.38 Billion JPY | 14.07% |
| 2014 Q2 | 2.06 Billion JPY | -1.77% |
| 2014 Q4 | 2.38 Billion JPY | 12.05% |
| 2014 Q3 | 2.13 Billion JPY | 3.03% |
| 2014 Q1 | 2.1 Billion JPY | 0.6% |
| 2013 Q2 | 2.15 Billion JPY | -3.78% |
| 2013 Q3 | 2.06 Billion JPY | -4.33% |
| 2013 Q4 | 2.09 Billion JPY | 1.42% |
| 2013 FY | 2.09 Billion JPY | -8.28% |
| 2013 Q1 | 2.24 Billion JPY | -1.75% |
| 2012 Q3 | 2.12 Billion JPY | -1.6% |
| 2012 Q4 | 2.28 Billion JPY | 7.12% |
| 2012 Q2 | 2.16 Billion JPY | -5.69% |
| 2012 FY | 2.28 Billion JPY | -1.44% |
| 2012 Q1 | 2.29 Billion JPY | -0.86% |
| 2011 Q2 | 2.36 Billion JPY | -0.7% |
| 2011 FY | 2.31 Billion JPY | 4.79% |
| 2011 Q3 | 2.32 Billion JPY | -1.71% |
| 2011 Q1 | 2.38 Billion JPY | 7.74% |
| 2011 Q4 | 2.31 Billion JPY | -0.35% |
| 2010 Q4 | 2.2 Billion JPY | 6.35% |
| 2010 FY | 2.2 Billion JPY | 31.83% |
| 2010 Q1 | 1.84 Billion JPY | 10.06% |
| 2010 Q2 | 1.83 Billion JPY | -0.23% |
| 2010 Q3 | 2.07 Billion JPY | 12.89% |
| 2009 Q4 | 1.67 Billion JPY | 2.29% |
| 2009 Q3 | 1.63 Billion JPY | -6.6% |
| 2009 Q2 | 1.75 Billion JPY | 0.0% |
| 2009 FY | 1.67 Billion JPY | -6.21% |
| 2008 Q3 | 1.77 Billion JPY | 0.0% |
| 2008 Q4 | 1.78 Billion JPY | 0.57% |
| 2008 FY | 1.78 Billion JPY | 15.34% |
| 2007 FY | 1.54 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 70.135% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.834% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 98.261% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 96.91% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 94.871% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 88.315% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 98.851% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | 37.016% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 90.527% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 93.375% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 85.875% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 81.29% |
| Tsumura & Co. | 117.61 Billion JPY | 98.294% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 92.371% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 81.325% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 98.015% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 89.644% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 86.155% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 96.248% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -2.768% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 90.397% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -764.558% |
| MedRx Co., Ltd | 10 Million JPY | -19960.35% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -25.644% |
| Solasia Pharma K.K. | 122 Million JPY | -1544.291% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -31476.184% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 90.167% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 97.994% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -4256.684% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 97.702% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | 11.482% |